FDA grants accelerated approval to naxitamab for high-risk neuroblastoma in bone or bone marrow

Hematology / Oncology News Burst
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news